Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001193125-15-089474
Filing Date
2015-03-12
Accepted
2015-03-12 17:25:09
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B2 d888300d424b2.htm 424B2 546385
2 GRAPHIC g888300g20f37.jpg GRAPHIC 142583
3 GRAPHIC g888300g25j45.jpg GRAPHIC 129442
4 GRAPHIC g888300g79y59.jpg GRAPHIC 35358
5 GRAPHIC g888300g88d27.jpg GRAPHIC 32644
  Complete submission text file 0001193125-15-089474.txt   1016755
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-188849 | Film No.: 15696898
SIC: 2834 Pharmaceutical Preparations